Autolus Therapeutics plc (FRA:6A3A)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $45.69M USD in the quarter ending June 30, 2026, with 118.37% growth. This brings the company's revenue in the last twelve months to $117.39M, up 293.55% year-over-year. In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 652.77% growth.

• Revenue (ttm): $117.39M
• Revenue Growth: +293.55%
• P/S Ratio: 5.42
• Revenue / Employee: $155.69K
• Employees: 754
• Market Cap: 556.50M EUR

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.39M	65.37M	652.77%
Dec 31, 2024	10.01M	8.32M	489.80%
Dec 31, 2023	1.70M	-4.68M	-73.38%
Dec 31, 2022	6.38M	4.87M	323.23%
Dec 31, 2021	1.51M	1.27M	522.73%
Dec 31, 2020	242.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Sep 30, 2018	-	-	-
Sep 30, 2017	-	-	-
Sep 30, 2016	-	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error